http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111714510-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7105 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7105 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-10 |
filingDate | 2020-05-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2021-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2021-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-111714510-B |
titleOfInvention | Application of long-chain non-coding RNA SNHG12 inhibitor in preparation of anti-osteoporosis drugs |
abstract | The invention belongs to the field of biomedicine, and particularly relates to application of a long-chain non-coding RNASNHG12 inhibitor in preparation of a drug for resisting osteoporosis. The invention relates to a siRNA inhibitor composition which utilizes siRNA as an RNASNNHG 12 inhibitor, wherein the siRNA inhibitor composition comprises one or more of sequences shown as SEQ ID No. 2-3, SEQ ID No. 4-5 and SEQ ID No. 6-7, the sequences are synthesized by designing the siRNA of a targeted SNHG12 gene, and after in vitro efficacy evaluation, the SNHG12 inhibitor is found to remarkably promote the osteogenic differentiation process of stem cells and show the potential of preparing a new medicament for treating osteoporosis. |
priorityDate | 2020-05-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 196.